Your browser doesn't support javascript.
loading
Surgical outcomes in patients with haemophilia A or B receiving extended half-life recombinant factor VIII and IX Fc fusion proteins: Real-world experience in the Nordic countries.
Lehtinen, Anna-Elina; Baghaei, Fariba; Astermark, Jan; Holme, Pål André.
Afiliación
  • Lehtinen AE; Coagulation Disorders Unit, Department of Haematology, Helsinki University Hospital Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland.
  • Baghaei F; Coagulation Centre, Department of Medicine/Section of Haematology and Coagulation, Sahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Astermark J; Institution for Translational Medicine, Lund University and Department for Haematology, Oncology and Radiation Physics, Skåne University Hospital, Malmö, Sweden.
  • Holme PA; Department of Haematology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Haemophilia ; 28(5): 713-719, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35575446
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Hemofilia B / Hemofilia A Tipo de estudio: Guideline / Observational_studies País/Región como asunto: Europa Idioma: En Revista: Haemophilia Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Hemofilia B / Hemofilia A Tipo de estudio: Guideline / Observational_studies País/Región como asunto: Europa Idioma: En Revista: Haemophilia Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article